Kolexia
Cohen Romain Oncologie médicale
Cohen Romain
Oncologie médicale
Hôpital Saint-Antoine
Paris, France
213 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Instabilité des microsatellites Tumeurs du côlon Métastase tumorale Adénocarcinome Tumeurs de l'estomac Tumeurs du rectum Carcinomes Tumeurs colorectales héréditaires sans polypose

Collaborateurs

Voir plus
Andre Thierry
Andre Thierry
Hôpital Saint-Antoine, Paris, France
Svrcek Magali
Svrcek Magali
Hôpital Saint-Antoine, Paris, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France

Industries

Voir plus
MSD
11 collaboration(s)
Dernière en 2023
BMS
6 collaboration(s)
Dernière en 2023
Edimark
4 collaboration(s)
Dernière en 2022
Pierre Fabre
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
HERIZON-GEA-01: A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)
Essai Clinique (Jazz Pharmaceuticals)   04 mars 2024
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective study
ESMO Gastrointestinal Oncology   01 mars 2024
Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   20 février 2024
7P Molecular targeted therapies based on metastatic site in first-line treatment for colorectal cancer patients: An ARCAD pooled analysis
Abstract Book of the ESMO Targeted Anticancer Therapies Congress (TAT) 26 - 28 February 2024   01 février 2024
RePERSO: Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib
Essai Clinique (CHU Rennes)   30 janvier 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation.
European journal of cancer (Oxford, England : 1990)   15 janvier 2024
Deficient mismatch repair/microsatellite unstable colorectal cancer: therapeutic advances and questions.
Therapeutic advances in medical oncology   09 janvier 2024
A 2023 inventory in oncology news.
Bulletin du cancer   05 janvier 2024
IMMUNO-BIL: Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy: a Randomized Non-comparative Two-arm Phase II Study
Essai Clinique (AstraZeneca)   03 janvier 2024
REPROGRAM-02: Induction Regorafenib in Combination With Metronomic Cyclophosphamide, Capecitabine, and Low-dose Aspirin Followed by Chemotherapy in Second Line Metastatic Colorectal Cancer Carcinoma An Open-label Randomized Phase II-III Study
Essai Clinique (CHU Besançon)   21 décembre 2023